Search

everythinglearnresearchcommunity

for

Search:↓

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Gray hair can potentially be reversed, leading to new treatments.

Licorice has many traditional health benefits, but more research is needed to fully support these claims.

Erdr1 could be a new marker for diagnosing hair loss.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

The document concludes that a complete skin restoration biomaterial does not yet exist, and more clinical trials are needed to ensure these therapies are safe and effective.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Secukinumab can cause hair loss, which may improve after stopping the medication.

SH-MSCs gel reduced IL-6 and increased TGF-β, suggesting it could treat alopecia.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Early and proper treatment is crucial for children with allergic conjunctivitis to avoid complications.

Low-level laser therapy may help with hair regrowth in alopecia areata but its effectiveness for psoriasis and atopic dermatitis needs more research.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Turkish pregnant women commonly experienced skin issues like itching and acne, and doctors mainly used topical treatments due to safety concerns during pregnancy.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Langerhans cells and melanocytes migrate to the skin and hair follicles during early human development.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

FFA patients have fewer melanocytes and thinner skin compared to others.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.